• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Severe nonuremic calciphylaxis due to hyperphosphatemia resolving with multimodality treatment including phosphate binders.

作者信息

Wanat Karolyn A, Stewart Campbell L, Negoianu Dan, Rosenbach Misha

出版信息

JAMA Dermatol. 2014 Jun;150(6):671-3. doi: 10.1001/jamadermatol.2013.7508.

DOI:10.1001/jamadermatol.2013.7508
PMID:24647547
Abstract
摘要

相似文献

1
Severe nonuremic calciphylaxis due to hyperphosphatemia resolving with multimodality treatment including phosphate binders.因高磷血症导致的严重非尿毒症性钙化防御通过包括磷结合剂在内的多模式治疗得以缓解。
JAMA Dermatol. 2014 Jun;150(6):671-3. doi: 10.1001/jamadermatol.2013.7508.
2
Phosphate binders, cardiovascular calcifications and mortality: do we need another survival study with sevelamer?磷酸盐结合剂、心血管钙化和死亡率：我们是否还需要用司维拉姆进行另一项生存研究？
J Nephrol. 2010 Nov-Dec;23(6):653-7.
3
[Treatment of hyperphosphatemia with sevelamer hydrochloride in CKD patients: effects on vascular calcification and mortality].[盐酸司维拉姆治疗慢性肾脏病患者高磷血症：对血管钙化和死亡率的影响]
Clin Calcium. 2010 Nov;20(11):1700-8.
4
[Phosphate binders in chronic kidney disease: the positions of sevelamer].慢性肾脏病中的磷结合剂：司维拉姆的地位
Ter Arkh. 2013;85(6):96-9.
5
Case of proximal calciphylaxis with protein S deficiency, successfully treated with multimodality therapy.蛋白S缺乏症伴近端钙化防御病例，采用多模式疗法成功治疗。
J Dermatol. 2012 Jul;39(7):657-9. doi: 10.1111/j.1346-8138.2011.01356.x. Epub 2011 Oct 5.
6
Efficacy and side effects of sevelamer hydrochloride as sole phosphate binder in peritoneal dialysis patients with severe hyperphosphatemia.
Perit Dial Int. 2008 Jan-Feb;28(1):93-5.
7
Comparison of efficacy of the phosphate binders nicotinic acid and sevelamer hydrochloride in hemodialysis patients.血液透析患者中烟酸和盐酸司维拉姆这两种磷结合剂的疗效比较。
Saudi J Kidney Dis Transpl. 2012 Sep;23(5):934-8. doi: 10.4103/1319-2442.100865.
8
Randomized controlled trial of bixalomer versus sevelamer hydrochloride in hemodialysis patients with hyperphosphatemia.比沙罗美与盐酸司维拉姆治疗血液透析高磷血症患者的随机对照试验
Ther Apher Dial. 2014 Apr;18(2):122-31. doi: 10.1111/1744-9987.12068. Epub 2013 Aug 27.
9
Ten-year experience with sevelamer and calcium salts as phosphate binders.使用司维拉姆和钙盐作为磷结合剂的十年经验。
Clin J Am Soc Nephrol. 2010 Jan;5 Suppl 1:S31-40. doi: 10.2215/CJN.05880809.
10
Comparison of sevelamer hydrochloride and sevelamer carbonate: risk of metabolic acidosis and clinical implications.碳酸司维拉姆与盐酸司维拉姆的比较：代谢性酸中毒风险及临床意义
Pharmacotherapy. 2009 May;29(5):554-61. doi: 10.1592/phco.29.5.554.

引用本文的文献

1
Practical Management of Adverse Events Associated With FGFR Inhibitors for Cholangiocarcinoma for the Advanced Practice Provider.晚期胆管癌患者使用FGFR抑制剂相关不良事件的高级实践提供者实用管理
J Adv Pract Oncol. 2024 Feb 14:1-27. doi: 10.6004/jadpro.2024.15.8.2.
2
Warfarin-Associated Nonuremic Calciphylaxis.华法林相关性非尿毒症性钙化防御
JAMA Dermatol. 2017 Mar 1;153(3):309-314. doi: 10.1001/jamadermatol.2016.4821.